Pediatric Praziquantel Consortium presenting at the 11th ECTMIH Meeting
Consortium partners will participate at the 11th European Congress on Tropical Medicine and International Health (ECTMIH) on September 16-20,...
Read more
News
09 July 2019
Consortium featured in 1st JAGntd newsletter
The Pediatric Praziquantel Consortium was featured in the first issue of the Japan Alliance on Global Neglected Tropical Diseases (JAGntd) newsletter.
Read more
News
09 May 2019
Taking the next step towards access with continued support from the GHIT Fund
The fourth research grant from the Global Health Innovative Technology (GHIT) Fund provides further support for the development, registration and access of...
Read more
News
03 April 2019
World Health Day: Working towards universal health coverage in Africa
The Pediatric Praziquantel Consortium marks the World Health Day through its continuous effort to register and launch a child-friendly and new praziquantel...
Read more
News
25 February 2019
From Africa to Asia: Important dialogues for the Pediatric Praziquantel Consortium
Consortium partners have been interacting with the local community in Ivory Coast and with experts from all over the world in Thailand to pave the way for...
Read more
News
14 January 2019
Publication: Relative bioavailability of two novel orally dispersible tablet formulations of praziquantel
In January 2019, researchers from the Pediatric Praziquantel Consortium published the results of two Phase I pharmacokinetic studies in healthy adult...
Read more
News
10 December 2018
Pediatric Praziquantel Consortium successfully completed Phase II in Ivory Coast
The important milestone of Last Patient Last Visit (LPLV) in the clinical Phase II trial was achieved on November 17, 2018
Read more
News
29 November 2018
Astellas Global Health Foundation Launches
On 20 November 2018, Astellas Pharma Inc. announced the launch of the Astellas Global Health Foundation (AGHF): a new international philanthropic...
Read more
News
31 October 2018
From the Program Lead: We have entered the pivotal Phase III stage!
With the Phase II trial showing good results on safety and efficacy for the new orally dispersible praziquantel tablets, the Consortium has entered the...
Read more
News
31 October 2018
Schistosomiasis in Kenya: an interview with Dr. Maurice R. Odiere
The forthcoming Phase III clinical trial of the Pediatric Praziquantel (PZQ) Consortium Formulation program will be conducted in Kenya, in addition to the...
Read more
News
31 October 2018
The Pediatric Praziquantel Consortium played a leading role at schistosomiasis events in Brazil and Korea
Through a series of meetings and events, the Pediatric Praziquantel Consortium presented the latest achievements of the program and aligned further on next...
Read more
News
31 October 2018
The new SCI elimination strategy
The Schistosomiasis Control Initiative (SCI) has achieved a lot since its foundation in 2002. It has helped to establish programs against parasitic worm...
